Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

Sustainability & Impact

Responsible Investment Strategy Health Objectives ESG Approach Publications

All

Reports

Policies

Sustainability related Disclosures - EU SFDR DISCLOSURES

Sustainability-related Disclosures - Loi énergie et climat (LEC)

Reports

OUR SUSTAINABILITY & IMPACT REPORT 2023

OUR SUSTAINABILITY & IMPACT REPORT 2023

download the full report

Go to

Policies

Responsible Investment Policy Remuneration Policy

Sustainability related Disclosures - EU SFDR DISCLOSURES

Statement on Principal Adverse Impacts SFDR Article 9 – Summary of Sustainability Disclosures SFDR Article 8 – Summary of Sustainability Disclosures Report on Principle Adverse Impacts (2023) SFDR Article 9 – MED Platform II – Periodic Disclosure (2023) SFDR Article 8 – MED Platform I – Periodic Disclosure (2023) SFDR Article 8+ – MED III – Periodic Disclosure (2023) SFDR Article 8 – MED II – Periodic Disclosure (2023) SFDR Article 8 – MED I – Periodic Disclosure (2023)

The Pre-contractual Disclosure document, Annex II, has been made available on our investor data platform.

Sustainability-related Disclosures - Loi énergie et climat (LEC)

Rapport Article 29 LEC (2023) – English Rapport Article 29 LEC (2023) – Français
  • ARCHIMED © 2025
  • Our Eco-Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top